title: RITED (Registro Italiano Test Eco-Dobutamina): side effects and complications of echo-dobutamine stress test in 3041 examinations.
abstract: OBJECTIVE
  The aim of the study was to report the incidence and clinical meaning of side-effects caused by echo-dobutamine testing in a large population and to evaluate any possible correlation between dobutamine dose and side-effects.
  
  
  METHODS
  The study population consisted of 3041 patients enrolled from January 1994 to August 1995 at 63 centers participating in the Italian Register of Echo-Dobutamine Testing (Registro Italiano Test Eco-Dobutamina, RITED). The four major indications were myocardial infarction older than one month (40.4%), recent myocardial infarction (22.7%), coronary artery disease without a history of myocardial infarction (10.8%) and suspected coronary artery disease (19.3%). Dobutamine was administered in a peripheral vein at 5, 10, 20, 30, 40 micrograms/kg/minute + atropine 1 mg in four divided doses of 0.25 mg/minute.
  
  
  RESULTS
  Severe complications were asystole, which went as high as 6" in one patient, and ventricular fibrillation in two patients. The clinical side-effects were headache (2.5%), hypotension (2.2%), nausea (1.7%), bradycardia (1.4%), palpitations (0.5%), tremors (0.3%), dyspnea (0.2%), paresthesia (0.2%) and hypertension (0.2%). Atrial arrhythmia was recorded in 10.6% of patients, while ventricular arrhythmia was recorded in 26.5%. The percentage of supraventricular and ventricular repetitive arrhythmia did not increase with dosage. The cumulative incidence of supraventricular and ventricular repetitive arrhythmia, considered as an interruption criteria, was 6.6% and 5.9%, respectively.
  
  
  CONCLUSIONS
  Echo-dobutamine stress test seems to be a very safe and reliable test for unmasking myocardial ischemia or viability in known or suspected coronary artery disease. It has been shown to be widely applicable in clinical practice for outpatients as well, as long as a protected environment is available.
authors.affiliation: Dipartimento Cardiologico, A. De Gasperis Ospedale Ca' Granda-Niguarda, Milano.
authors.forename: A
authors.initials: A
authors.lastname: Pezzano
authors.forename: F
authors.initials: F
authors.lastname: Gentile
authors.forename: A
authors.initials: A
authors.lastname: Mantero
authors.forename: A
authors.initials: A
authors.lastname: Morabito
authors.forename: P
authors.initials: P
authors.lastname: Ravizza
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001281:Atrial Fibrillation / Q000139:chemically induced; D005117:Cardiac Complexes, Premature / Q000139:chemically induced; D003327:Coronary Disease / Q000175:diagnosis; D003627:Data Interpretation, Statistical; D004280:Dobutamine / Q000008:administration & dosage / Q000009:adverse effects*; D004452:Echocardiography / Q000379:methods; D005069:Evaluation Studies as Topic; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000175:diagnosis*
chemical_list: D004280:Dobutamine